Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer

Published:2013-02 Issue:2 Volume:38 Page:88-92
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Yuan Jie,Liu Congjin,Liu Xingdang,Wang Yuankai,Kuai Dayu,Zhang Guangming,Zaknun John J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference20 articles.

1. Bone metastases: molecular mechanisms and novel therapeutic interventions.;Papachristou;Med Res Rev,2012

2. Radiopharmaceuticals for painful bone metastases: perspective from radiation oncology.;Barnes;J Support Oncol,2011

3. Radionuclide therapy of bone metastases.;Fischer;Breast Care (Basel),2012

4. Radionuclide treatment of painful bone metastases in patients with breast cancer: a systematic review.;Christensen;Cancer Treat Rev,2012

5. Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.;Horwich;Ann Oncol,2009

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

2. Lutetium-177 radioisotope and therapeutic radiopharmaceuticals: Production, separation and purification, chelation labeling and clinical application;Chinese Science Bulletin;2024-04-12

3. Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases;EJNMMI Research;2024-03-22

4. Kemik Metastazlarının Tedavisinde Radyofarmasötiklerin Rolü;Fabad Journal of Pharmaceutical Sciences;2023-05-02

5. Safety and Efficacy of 68Ga- or 177Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases;Clinical Nuclear Medicine;2023-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3